Skip to Main Content

Vitamin D OP remote study

  • Study HIC#:2000028035
  • Last Updated:07/15/2021

The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.

  • Age18 years - 50 years
  • GenderBoth
  • Start Date06/03/2020
  • End Date05/30/2025

Trial Purpose and Description

This study aims to determine whether acute calcitriol (versus placebo) administration enhances the neurocognitive effects of of current stimulant medications as measured by tasks of vigilance/attention, spatial working memory, and reversal learning in individuals with (attention deficit hyperactivity disorder (ADHD) using a randomized, double-blind, placebo controlled, within-subject, two-day study design

Eligibility Criteria

This study aims to determine whether acute calcitriol (versus placebo) administration enhances the neurocognitive effects of of current stimulant medications as measured by tasks of vigilance/attention, spatial working memory, and reversal learning in individuals with (attention deficit hyperactivity disorder (ADHD) using a randomized, double-blind, placebo controlled, within-subject, two-day study design.

Principal Investigator

Sub-Investigator

For more information about this study, contact:

Or contact the Help us Discover team on: